Van Lanschot Kempen Investment Management N.V. Purchases 20,614 Shares of Kenvue Inc. (NYSE:KVUE)

Van Lanschot Kempen Investment Management N.V. lifted its position in shares of Kenvue Inc. (NYSE:KVUE) by 1.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,353,596 shares of the company’s stock after purchasing an additional 20,614 shares during the quarter. Van Lanschot Kempen Investment Management N.V. owned about 0.07% of Kenvue worth $28,899,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Handelsbanken Fonder AB boosted its holdings in shares of Kenvue by 2.9% during the 4th quarter. Handelsbanken Fonder AB now owns 742,184 shares of the company’s stock valued at $15,846,000 after buying an additional 21,222 shares in the last quarter. Alberta Investment Management Corp lifted its position in Kenvue by 23.2% during the 4th quarter. Alberta Investment Management Corp now owns 582,895 shares of the company’s stock valued at $12,445,000 after acquiring an additional 109,700 shares during the period. Longbow Finance SA boosted its stake in Kenvue by 5.0% during the fourth quarter. Longbow Finance SA now owns 280,568 shares of the company’s stock worth $5,990,000 after acquiring an additional 13,287 shares in the last quarter. Steward Partners Investment Advisory LLC grew its holdings in Kenvue by 143.1% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 47,938 shares of the company’s stock worth $1,023,000 after purchasing an additional 28,216 shares during the period. Finally, CORDA Investment Management LLC. increased its stake in shares of Kenvue by 1.4% during the fourth quarter. CORDA Investment Management LLC. now owns 1,253,096 shares of the company’s stock valued at $26,754,000 after purchasing an additional 17,466 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on KVUE. Royal Bank of Canada reissued a “sector perform” rating and issued a $24.00 price target on shares of Kenvue in a research report on Monday, February 3rd. Barclays dropped their target price on Kenvue from $23.00 to $22.00 and set an “equal weight” rating on the stock in a report on Monday, April 14th. Redburn Atlantic initiated coverage on Kenvue in a report on Thursday, April 10th. They set a “neutral” rating and a $23.50 price target for the company. UBS Group dropped their price target on shares of Kenvue from $23.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, February 7th. Finally, Citigroup increased their price objective on shares of Kenvue from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Monday, April 14th. Eight equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $24.42.

Kenvue Trading Up 3.0 %

NYSE:KVUE opened at $23.42 on Monday. The company has a 50 day simple moving average of $22.91 and a two-hundred day simple moving average of $22.41. The company has a market cap of $44.93 billion, a PE ratio of 44.19, a price-to-earnings-growth ratio of 2.62 and a beta of 1.02. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $24.46.

Kenvue (NYSE:KVUE) last posted its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. Research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th will be given a $0.205 dividend. The ex-dividend date is Wednesday, May 14th. This represents a $0.82 annualized dividend and a yield of 3.50%. Kenvue’s payout ratio is presently 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.